- Home
- USBC vs BRTX Comparison
USBC vs BRTX Comparison
Compare USBC & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USBC
- BRTX
- Stock Information
- Founded
- USBC N/A
- BRTX 1997
- Country
- USBC
- BRTX United States
- Employees
- USBC N/A
- BRTX N/A
- Industry
- USBC
- BRTX Managed Health Care
- Sector
- USBC
- BRTX Health Care
- Exchange
- USBC Nasdaq
- BRTX Nasdaq
- Market Cap
- USBC 14.5M
- BRTX 12.5M
- IPO Year
- USBC N/A
- BRTX N/A
- Fundamental
- Price
- USBC $0.83
- BRTX $1.60
- Analyst Decision
- USBC
- BRTX
- Analyst Count
- USBC 0
- BRTX 0
- Target Price
- USBC N/A
- BRTX N/A
- AVG Volume (30 Days)
- USBC N/A
- BRTX 96.5K
- Earning Date
- USBC N/A
- BRTX 08-12-2025
- Dividend Yield
- USBC N/A
- BRTX N/A
- EPS Growth
- USBC N/A
- BRTX N/A
- EPS
- USBC N/A
- BRTX N/A
- Revenue
- USBC N/A
- BRTX $605,200.00
- Revenue This Year
- USBC N/A
- BRTX $232.67
- Revenue Next Year
- USBC N/A
- BRTX $52.92
- P/E Ratio
- USBC N/A
- BRTX N/A
- Revenue Growth
- USBC N/A
- BRTX 247.62
- 52 Week Low
- USBC N/A
- BRTX $1.21
- 52 Week High
- USBC N/A
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- USBC N/A
- BRTX 50.43
- Support Level
- USBC N/A
- BRTX $1.56
- Resistance Level
- USBC N/A
- BRTX $1.89
- Average True Range (ATR)
- USBC 0.00
- BRTX 0.09
- MACD
- USBC 0.00
- BRTX 0.01
- Stochastic Oscillator
- USBC 0.00
- BRTX 30.95
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.